J. Fra

Fotemustine Compared With Dacarbazine in Patients With Disseminated Malignant Melanoma: A Phase III Study

Marie‐Françoise Avril, Steinar Aamdal, Jean‐Jacques Grob et al. · Journal of Clinical Oncology · 2004 · 470 citations

Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study

Xavier García del Muro, Antonio López–Pousa, Joan Maurel et al. · Journal of Clinical Oncology · 2011 · 293 citations

Efficacy of Sequential High-Dose Doxorubicin and Ifosfamide Compared With Standard-Dose Doxorubicin in Patients With Advanced Soft Tissue Sarcoma: An Open-Label Randomized Phase II Study of the Spanish Group for Research on Sarcomas

Joan Maurel, Antonio López–Pousa, R. de las Peñas et al. · Journal of Clinical Oncology · 2009 · 73 citations · Full text

Role of Surgery in Patients with Recurrent, Metastatic, or Unresectable Locally Advanced Gastrointestinal Stromal Tumors Sensitive to Imatinib: A Retrospective Analysis of the Spanish Group for Research on Sarcoma (GEIS)

Jordi Rubió‐Casadevall, Javier Martínez‐Trufero, Xabier García‐Albéniz et al. · Annals of Surgical Oncology · 2015 · 57 citations

Spanish Group, Surgical Oncology, Gastrointestinal Oncology +8

Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy

Emilio Esteban, Luis González de Sande, Yolanda Fernández et al. · Annals of Oncology · 2003 · 54 citations · Full text

Oncology, Docetaxel Versus Paclitaxel, Cancer Management +10